Clinical Trial Update: Assess Efficacy, Immune Response & Safety of 2 Doses of Oral Live Attenuated HRV Vaccine at Different Viral Concentrations in Healthy Infants [Phase 2]

View source ↗

Summary

A Phase 2 trial completed in healthy infants evaluated the efficacy, immune response, and safety of two doses of an oral live attenuated HRV (rotavirus) vaccine…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Oral live attenuated HRV vaccine (rotavirus vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis B | Phase 2 | Status: COMPLETED